Commonwealth Equity Services LLC Decreases Stake in Colgate-Palmolive (NYSE:CL)

Commonwealth Equity Services LLC lessened its position in shares of Colgate-Palmolive (NYSE:CL) by 24.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 256,034 shares of the company’s stock after selling 82,456 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Colgate-Palmolive were worth $23,276,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. Kohmann Bosshard Financial Services LLC bought a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $26,000. Centricity Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at approximately $27,000. Union Bancaire Privee UBP SA purchased a new position in shares of Colgate-Palmolive in the 4th quarter worth approximately $32,000. Briaud Financial Planning Inc bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at approximately $32,000. Finally, Wintrust Investments LLC purchased a new stake in Colgate-Palmolive during the 4th quarter valued at $33,000. Institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

CL has been the topic of several recent analyst reports. UBS Group reduced their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Stifel Nicolaus reduced their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday, February 3rd. Raymond James restated an “outperform” rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Barclays reduced their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. Finally, JPMorgan Chase & Co. boosted their price objective on Colgate-Palmolive from $97.00 to $99.00 and gave the company an “overweight” rating in a report on Friday. One analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $101.72.

Colgate-Palmolive Price Performance

Shares of CL opened at $89.80 on Monday. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The company has a 50 day moving average price of $89.02 and a 200-day moving average price of $94.67. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The stock has a market capitalization of $72.87 billion, a PE ratio of 25.51, a PEG ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the business earned $0.87 earnings per share. Equities analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.